Assignee
OGD2 PHARMA
FR·6 granted patents·3 pending applications·5 citations·filing 2014–2023
Top patents by PatentIndex Score
9 records- 0171US10745489B2Targeting o-acetylated gd2 ganglioside as a new therapeutic and diagnostic strategy for Cancer Stem Cells cancerOGD2 PHARMA·Filed 2018·Granted Aug 18, 2020·1 cites·12 claims
- 0269US11697689B2Use of antibody against O-acetylated GD2 ganglioside to improve the therapeutic potential of drugsOGD2 PHARMA·Filed 2017·Granted Jul 11, 2023·1 cites·18 claims
- 0369US2023148349A1Humanized antibody against o-acetylated gd2 ganglioside (oacgd2)OGD2 PHARMA·Filed 2022·Application pending·0 cites
- 0467US10611848B2Antibody against GD2-O-acetylated ganglioside with pro-apoptotic activityOGD2 PHARMA·Filed 2014·Granted Apr 7, 2020·1 cites·23 claims
- 0567US10000575B2Targeting O-acetylated GD2 ganglioside as a new therapeutic and diagnostic strategy for cancer stem cells cancerOGD2 PHARMA·Filed 2014·Granted Jun 19, 2018·2 cites·11 claims
- 0663US2023416398A1Use of antibody against o-acetylated gd2 ganglioside to improve the therapeutic potential of drugsOGD2 PHARMA·Filed 2023·Application pending·0 cites
- 0759US11440968B2Humanized antibody against O-acetylated GD2 ganglioside (OAcGD2)OGD2 PHARMA·Filed 2017·Granted Sep 13, 2022·0 cites·21 claims
- 0856US2024142457A1Use of casd1 as a biomarker of a cancer expressing the o-acetylated-gd2 gangliosideOGD2 PHARMA·Filed 2022·Application pending·0 cites
- 0945US10669328B2Human IgG1 derived antibody with pro-apoptotic activityOGD2 PHARMA·Filed 2014·Granted Jun 2, 2020·0 cites·25 claims
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →